Measles (ICD-11: 1F03) - Complete Coding and Diagnostic Guide

1. Introduction

Measles is a highly contagious viral disease that remains one of the leading causes of preventable morbidity and mortality in unvaccinated populations around the world. Caused by Morbillivirus, an RNA virus of the Paramyxoviridae family, measles is characterized by a distinct clinical syndrome that includes maculopapular rash, high fever, cough, rhinitis and conjunctivitis, in addition to the pathognomonic presence of Koplik spots on the oral mucosa.

The clinical importance of measles transcends its initial presentation, as the disease can result in serious complications such as pneumonia, encephalitis, otitis media and, in rare cases, subacute sclerosing panencephalitis. The disease predominantly affects children, but can affect individuals of any age, especially in populations with low vaccination coverage. Transmission occurs extremely efficiently through respiratory droplets and aerosols, with an infected individual able to transmit the virus to 12 to 18 susceptible people in enclosed environments.

From a public health perspective, measles represents a sensitive indicator of the quality of immunization programs. Measles outbreaks frequently signal gaps in vaccination coverage and epidemiological surveillance. Correct coding of measles in the ICD-11 system is critical for accurate epidemiological monitoring, adequate allocation of health resources, planning of vaccination campaigns and evaluation of the effectiveness of control interventions. Precise identification through the code 1F03 allows case tracking, analysis of temporal and spatial trends, and facilitates essential international comparisons for the global objective of measles elimination.

2. Correct ICD-11 Code

Code: 1F03
Description: Measles
Parent category: Viral infections characterized by lesions on skin or mucous membranes

The official ICD-11 definition describes measles as a disease of the respiratory system caused by infection with Morbillivirus, characterized by maculopapular rash, fever, cough, conjunctivitis, or malaise. The disease may also manifest small white spots with white-bluish centers inside the mouth, known as Koplik spots, which are considered pathognomonic for measles and typically appear 2-3 days before the cutaneous exanthem.

Transmission occurs primarily through inhalation of infected respiratory secretions, airborne transmission through aerosols, or direct contact with nasopharyngeal secretions. The virus can remain viable in the air for up to two hours after coughing or sneezing by an infected person, which explains its high contagiousness. The incubation period ranges from 7 to 21 days, with an average of 10 to 14 days between exposure and symptom onset.

Diagnostic confirmation is made through detection of Morbillivirus RNA by molecular biology techniques (RT-PCR) or by detection of measles-specific IgM antibodies in serum. IgM serology typically becomes positive 3-4 days after rash onset and remains detectable for 4-8 weeks. Detection of IgG with a fourfold increase between acute and convalescent phase samples also confirms the diagnosis. Viral isolation in cell culture, although the gold standard, is rarely used in clinical practice due to technical complexity and time required.

3. When to Use This Code

The code 1F03 should be applied in specific clinical situations where the diagnosis of measles is confirmed or highly probable based on clinical and laboratory criteria:

Scenario 1: Patient with laboratory-confirmed classic measles syndrome
A patient presents with high fever (above 38.5°C), followed by cough, rhinitis, and conjunctivitis (the three "Cs" of measles), subsequently developing maculopapular rash that begins on the face and retroauricular region, progressing cephalocaudally. Serology reveals positive IgM for measles or RT-PCR detects viral RNA. This is the most straightforward scenario for application of code 1F03, representing a confirmed case of measles.

Scenario 2: Identification of Koplik spots in patient with febrile syndrome
During physical examination of a patient with fever, cough, and conjunctivitis, the physician identifies small white spots with erythematous halo on the buccal mucosa, near the molars. These Koplik spots are pathognomonic for measles and appear in the prodromal period, before the cutaneous rash. Even while awaiting laboratory confirmation, the presence of these lesions in a compatible epidemiological context justifies coding as 1F03.

Scenario 3: Epidemiologically linked case during outbreak
In the context of a confirmed measles outbreak, an unvaccinated patient develops a clinical picture compatible with high fever, conjunctivitis, rhinitis, cough, and characteristic maculopapular rash after documented contact with a confirmed case. Even without individual laboratory confirmation, the strong epidemiological link and typical clinical presentation permit coding as 1F03, especially when laboratory resources are limited during extensive outbreaks.

Scenario 4: Respiratory complication secondary to measles
A patient diagnosed with measles develops pneumonia as a complication of viral infection. Code 1F03 should be used as the principal diagnosis and may be complemented with a specific code for secondary viral or bacterial pneumonia. Pneumonia is one of the most common complications of measles, occurring through direct viral invasion or bacterial superinfection.

Scenario 5: Measles in immunocompromised patient with atypical presentation
A patient with immunodeficiency develops persistent fever, respiratory symptoms, and atypical rash (may be less pronounced or absent). Confirmation by RT-PCR detects Morbillivirus. Even with clinical presentation modified by immunosuppression, code 1F03 is appropriate, as infection with measles virus is confirmed. These cases frequently present with a more severe and prolonged course.

Scenario 6: Retrospective diagnosis through seroconversion
A patient presented with febrile illness with rash several weeks ago, initially undiagnosed. Subsequent serology demonstrates seroconversion with specific IgG for measles at significantly elevated levels compared to previous sample, confirming recent infection. Code 1F03 is appropriate for documenting this retrospective diagnosis, important for epidemiological surveillance.

4. When NOT to Use This Code

It is essential to distinguish measles from other conditions that may present with similar clinical manifestations but require different codes:

Rubella: Although it also causes rash and fever, rubella presents with milder constitutional symptoms, prominent retroauricular and occipital lymphadenopathy, and absence of Koplik spots. The rubella rash is typically finer and less confluent. Rubella requires a specific code different from 1F03.

Exanthem subitum (roseola infantum): Caused by human herpesvirus 6, it is characterized by high fever that abruptly subsides when the rash appears, unlike measles where fever persists during the exanthematous period. The distinct clinical presentation and etiologic agent require different coding.

Scarlet fever: Although it causes rash and fever, scarlet fever is caused by Streptococcus pyogenes, presents with strawberry tongue, sandpaper-textured rash and subsequent desquamation, and responds to antibiotics. This bacterial condition requires a specific code for streptococcal infections.

Erythema infectiosum (fifth disease): Caused by parvovirus B19, it is characterized by the classic "slapped cheek" rash and lacy pattern on the extremities, without the prominent respiratory symptoms of measles. Requires a code different from 1F03.

Drug reactions with rash: Many medications can cause rashes that mimic viral infections. The absence of prodromal respiratory symptoms, history of recent medication introduction, and absence of laboratory confirmation for measles indicate that codes for adverse drug reactions are more appropriate.

Dengue and other arboviruses: In endemic regions, they may present with fever and rash, but the epidemiologic context, presence of leukopenia and thrombocytopenia, absence of respiratory symptoms, and specific serology direct toward codes for arboviruses.

Code 1F03 should also not be used alone for measles vaccination (which has its own code in the procedures chapter) or to document immunity to measles without active disease.

5. Step-by-Step Coding Process

Step 1: Assess diagnostic criteria

Confirmation of measles diagnosis requires systematic evaluation of clinical and laboratory criteria. Clinically, one must identify the classic triad of high fever (typically above 38.3°C), respiratory symptoms (cough, rhinorrhea) and conjunctivitis, followed by characteristic maculopapular rash. The rash begins on the face and hairline, progressing to the neck, trunk, and extremities over 3-4 days.

The investigation should include detailed history of vaccination, recent exposures to suspected or confirmed cases, and recent travel. Careful physical examination should search for Koplik spots on the buccal mucosa, which when present are practically diagnostic. Laboratory evaluation includes blood sample collection for IgM serology (ideally 3-28 days after rash onset) and nasopharyngeal swab or urine for viral RNA detection by RT-PCR. Complete blood count may show leukopenia with relative lymphopenia. Chest radiography may be necessary if pulmonary complications are suspected.

Step 2: Check specifiers

The code 1F03 in ICD-11 may require additional specifiers depending on clinical presentation and complications. One should document disease severity (mild, moderate, severe), presence of complications (pneumonia, encephalitis, otitis media, diarrhea), and patient immunological status (immunocompetent versus immunocompromised).

Duration of symptoms should be recorded, as the typical course includes prodromal period of 2-4 days, followed by exanthematous period of 5-6 days. Atypical presentations in previously vaccinated patients (modified measles) or immunocompromised individuals should be specifically documented. The source of infection (if known) and epidemiological link with other cases are valuable information for epidemiological surveillance.

Step 3: Differentiate from other codes

Poxvirus infections: These infections, including monkeypox, present with cutaneous lesions that evolve from macules to papules, vesicles, and pustules, unlike the non-vesicular maculopapular rash of measles. Poxvirus lesions are typically deeper, umbilicated, and evolve synchronously, while measles rash is superficial and does not form vesicles.

Human papillomavirus infection of skin or mucous membrane: HPV causes chronic verrucous lesions or papillomas, without systemic manifestations such as fever and respiratory symptoms. The presentation is completely distinct from the acute febrile exanthematous picture of measles, being easily differentiable clinically.

Varicella zoster infections: Varicella (chickenpox) causes pruritic vesicular rash that evolves in different stages simultaneously (regional polymorphism), unlike the maculopapular rash of measles. Herpes zoster presents with unilateral dermatomeric distribution with grouped vesicles on erythematous base, clearly distinct from the distribution pattern of measles.

Step 4: Required documentation

Adequate documentation for measles coding should include:

Checklist of mandatory information:

Date of onset of prodromal symptoms
Date of rash onset
Detailed description of symptoms (fever, cough, rhinorrhea, conjunctivitis)
Characteristics of rash (distribution, progression, appearance)
Presence or absence of Koplik spots
Complete vaccination status (dates and doses of measles vaccine)
Exposure history (contacts, travel, local outbreaks)
Laboratory test results (IgM/IgG serology, RT-PCR)
Complications developed
Treatment instituted
Notification to public health authorities

The record should be sufficiently detailed to justify coding and allow epidemiological tracking. Photographs of the rash and Koplik spots, when possible, are valuable documentation. Mandatory notification to health authorities is required in virtually all jurisdictions due to the public health importance of measles.

6. Complete Practical Example

Clinical Case:

A 7-year-old patient is brought to the emergency department by parents with a history of high fever (39.5°C) for 4 days, accompanied by intense dry cough, watery rhinorrhea, and red eyes with photophobia. The parents report that the child is irritable, with poor appetite and refusing food. Twenty-four hours ago, a reddened rash appeared that started behind the ears and on the forehead, progressively spreading to the face, neck, and trunk.

In the history, the parents admit that the child did not receive any dose of the measles vaccine due to personal beliefs against vaccination. They report that approximately two weeks ago they attended a community event where they later learned there was a child with confirmed measles.

On physical examination, the child appears febrile (39.2°C), with bilateral non-purulent conjunctivitis, clear rhinorrhea, and occasional cough during the examination. The skin shows a confluent erythematous maculopapular exanthem on the face, neck, and upper trunk, with individualized lesions on the upper extremities. The exanthem is not pruritic. Upon examining the oral cavity with a flashlight, small white spots with an erythematous halo are identified on the buccal mucosa, near the lower molars, consistent with Koplik spots. Pulmonary auscultation reveals bilateral vesicular murmur present without adventitious sounds. Oropharyngeal examination shows diffuse hyperemia.

Step-by-Step Coding:

Analysis of criteria:

Clinical criteria present:
- High fever (39.5°C) for more than 3 days
- Classic triad: cough + rhinorrhea + conjunctivitis
- Maculopapular exanthem with characteristic cephalocaudal progression
- Koplik spots identified (pathognomonic)
Epidemiological context:
- Unvaccinated child (susceptible)
- Documented exposure to confirmed case 2 weeks ago
- Compatible incubation period (10-14 days)
Diagnostic confirmation:
- Blood collection for anti-measles IgM serology
- Nasopharyngeal swab collection for RT-PCR
- Immediate notification to health authorities

Code selected: 1F03 - Measles

Complete justification:

The code 1F03 is fully justified in this case by the presence of all classic diagnostic elements of measles. The triad of cough, rhinorrhea, and conjunctivitis associated with high fever constitutes the characteristic prodromal period. The identification of Koplik spots, although present in only a proportion of cases (often not visualized as they disappear rapidly), is practically pathognomonic when identified, making the clinical diagnosis highly reliable even before laboratory confirmation.

The pattern of exanthem progression (onset on the face and retroauricular region with downward progression) is highly characteristic of measles, differentiating it from other viral rashes. The history of non-vaccination establishes susceptibility, and the documented exposure two weeks ago provides an epidemiological link consistent with the typical incubation period.

The absence of vesicles rules out varicella, the intensity of respiratory and constitutional symptoms rules out rubella, and the persistence of fever during the exanthematous period rules out roseola infantum. Subsequent laboratory confirmation (positive IgM serology collected on day 5 of the exanthem and positive RT-PCR from the nasopharyngeal swab) validated the clinical diagnosis.

Applicable complementary codes:

Code for contact/exposure to communicable disease (if applicable in public health documentation)
If complications such as pneumonia or otitis media develop, specific additional codes should be added
Code for non-vaccination status may be relevant in some documentation contexts

The case was reported to public health authorities according to protocol, and respiratory isolation measures were implemented. Guidance was provided to the parents regarding warning signs for complications, and outpatient follow-up was scheduled.

7. Related Codes and Differentiation

Within the Same Category:

Poxvirus Infections

Poxviruses cause diseases with skin lesions that progress through well-defined stages: macule → papule → vesicle → pustule → crust. Monkeypox, for example, presents with deep lesions, frequently umbilicated, that evolve synchronously (all at the same stage at a given time). Unlike measles, there is frequently prominent lymphadenopathy, especially cervical and inguinal, which may precede the exanthem. The prodromal period may include fever, but upper respiratory symptoms are not as pronounced as in measles. The main difference lies in lesion morphology: vesiculopustular in poxviruses versus non-vesicular maculopapular in measles. The poxvirus code should be used when there is confirmation of infection by a virus of this genus, whether by PCR, electron microscopy, or viral culture.

Human Papillomavirus Infection of Skin or Mucous Membrane

HPV infections manifest as chronic verrucous lesions (common warts, plantar warts, flat warts) or papillomas on mucous membranes. These lesions are localized, non-inflammatory, asymptomatic or minimally symptomatic, without systemic manifestations. There is no fever, constitutional symptoms, or disseminated rash. The course is chronic, with lesions persisting for months to years, contrasting dramatically with the acute self-limited course of measles. HPV requires direct contact for transmission and is not transmitted by airborne route. Use HPV code when there are characteristic verrucous lesions, confirmation by biopsy showing koilocytosis, or molecular detection of HPV. The clinical context is completely distinct from measles.

Varicella Zoster Virus Infections

Varicella-zoster virus causes two distinct clinical manifestations: varicella (primary infection) and herpes zoster (reactivation). Varicella presents with pruritic vesicular exanthem that evolves in different stages simultaneously (regional polymorphism), with lesions beginning on the trunk and face. The vesicles are superficial, on an erythematous base, and rupture easily forming crusts. Pruritus is characteristic and prominent. Herpes zoster manifests as painful vesicular eruption in unilateral dermatomeric distribution, frequently preceded by neuropathic pain. Both manifestations differ fundamentally from measles by the vesicular nature of the lesions and absence of the characteristic respiratory triad. Use varicella-zoster codes when there are characteristic vesicles, typical distribution (generalized in varicella, dermatomeric in zoster), or laboratory confirmation of VZV.

Differential Diagnoses:

Rubella: Differentiated by milder constitutional symptoms, prominent retroauricular and occipital lymphadenopathy, finer and more pink exanthem that disappears more rapidly (2-3 days), absence of Koplik spots. Specific serological confirmation for rubella is necessary.

Roseola infantum: Characteristic in children 6 months to 2 years old, with high fever that ceases abruptly when the exanthem appears (fever-exanthem inverse to measles). There are no significant respiratory symptoms.

Scarlet fever: Caused by Streptococcus pyogenes, presents with strawberry tongue, exanthem rough to touch (sandpaper texture), Pastia lines (accentuation in skin folds), and subsequent desquamation. Responds to antibiotics.

Dengue: In endemic regions, it may cause fever and exanthem, but presents with leukopenia, thrombocytopenia, intense retro-orbital pain, and absence of prominent upper respiratory symptoms.

8. Differences with ICD-10

In ICD-10, measles is coded as B05, with subcategories for specific complications:

B05.0 - Measles complicated by encephalitis
B05.1 - Measles complicated by meningitis
B05.2 - Measles complicated by pneumonia
B05.3 - Measles complicated by otitis media
B05.4 - Measles with intestinal complications
B05.8 - Measles with other complications
B05.9 - Measles without complication

The transition to ICD-11 with code 1F03 represents significant structural changes:

Main changes:

Reformulated hierarchical structure: In ICD-11, measles is categorized under "Viral infections characterized by skin or mucous membrane lesions," emphasizing its primary clinical presentation, whereas in ICD-10 it was under "Viral diseases characterized by skin and mucous membrane lesions."
Post-coordinated coding system: ICD-11 allows adding extension codes to specify complications, severity, causative agents, and other details, rather than requiring completely different codes for each complication as in ICD-10.
More detailed definitions: ICD-11 provides more elaborate definitions including specific diagnostic methods (RT-PCR, IgM serology), whereas ICD-10 had more concise definitions.
Better alignment with modern clinical practice: The explicit inclusion of molecular diagnostic methods reflects technological advances not available when ICD-10 was developed.

Practical impact:

For healthcare professionals, the transition requires familiarity with the new code 1F03 and understanding of the post-coordination system to document complications. Electronic medical record systems require updating to support the new structure. Epidemiological surveillance benefits from the greater granularity and precision of ICD-11, allowing for more sophisticated analyses. However, during the transition period, it may be necessary to maintain mapping between ICD-10 and ICD-11 codes for historical series analyses and temporal comparisons.

9. Frequently Asked Questions

How is measles diagnosed?

The diagnosis of measles combines clinical evaluation and laboratory confirmation. Clinically, the physician looks for the characteristic presentation: prodromal period of 2-4 days with high fever, cough, rhinorrhea and conjunctivitis, followed by maculopapular exanthem that begins on the face and progresses cephalocaudally. The identification of Koplik spots on the oral mucosa, when present, is practically diagnostic. Laboratory confirmation is performed through serology for detection of measles-specific IgM antibodies (collected ideally 3-28 days after exanthem onset) or detection of viral RNA by RT-PCR in nasopharyngeal swab, blood, or urine samples. In contexts of confirmed outbreaks, cases with clear epidemiological linkage can be classified as confirmed even without individual laboratory testing.

Is treatment available in public health systems?

Measles has no specific antiviral treatment, therefore management is essentially supportive and is available in public health systems globally. Treatment includes rest, adequate hydration, antipyretics for fever control, and nutritional support. Vitamin A supplementation is recommended especially in children, as it significantly reduces morbidity and mortality, being available in public health programs. Complications such as secondary bacterial pneumonia or otitis media require appropriate antibiotics. Severe cases with complications may require hospitalization for respiratory support, intravenous hydration, and management of neurological complications. Prevention through vaccination is universally available in public immunization programs and represents the most cost-effective intervention.

How long does treatment and the disease last?

The natural course of uncomplicated measles follows a relatively predictable pattern. The incubation period (exposure to first symptoms) lasts 7-21 days, with an average of 10-14 days. The prodromal period, characterized by fever and respiratory symptoms, lasts 2-4 days. The exanthem persists for 5-6 days, beginning to fade in the same order it appeared, frequently leaving fine desquamation. Fever generally subsides 2-3 days after exanthem onset. Cough may persist for 1-2 weeks after exanthem resolution. The total period of active disease is typically 7-10 days, although complete recovery with resolution of all symptoms may take 2-3 weeks. The patient is considered contagious from 4 days before to 4 days after exanthem onset, a period during which isolation measures are necessary. In immunocompromised patients, the disease may have a prolonged and atypical course.

Can this code be used in medical certificates?

Yes, code 1F03 can and should be used in medical certificates when appropriate. Measles is a notifiable disease that requires absence from school, work, and social activities during the period of transmissibility. Medical certificates should specify the diagnosis of measles and recommend respiratory isolation for at least 4 days after exanthem onset, or longer in cases of immunocompromised individuals. Proper documentation is important not only to justify the patient's absence, but also to alert institutions about the need for control measures, identification of susceptible contacts, and possible need for post-exposure prophylaxis. In some contexts, it may be appropriate to use descriptive terminology ("febrile exanthematous disease") in non-confidential documents to preserve privacy, reserving the specific code for protected medical records.

Who should receive post-exposure vaccination?

Susceptible contacts of measles cases may benefit from post-exposure interventions. The measles vaccine (usually as MMR) administered within 72 hours after exposure can prevent or modify the disease. Normal human immunoglobulin can be administered up to 6 days after exposure for individuals with contraindication to the vaccine (immunocompromised, pregnant women, infants under 6 months), providing temporary passive protection. Priority for post-exposure prophylaxis includes: infants 6-11 months (who may receive an additional vaccine dose), immunocompromised persons, susceptible pregnant women, and non-immune healthcare workers. Rapid assessment of vaccination and immunological status of contacts is crucial, as the window of opportunity for effective intervention is limited.

Can measles occur in vaccinated people?

Yes, although rare, measles can occur in previously vaccinated people, a phenomenon known as "vaccine failure." There are two types: primary failure (absence of initial immunological response to the vaccine, occurring in approximately 2-5% of vaccinees after one dose) and secondary failure (gradual loss of immunity over time). Measles in vaccinated people generally presents with a modified course with milder symptoms, less intense fever, shorter incubation period, and less pronounced exanthem. Administration of two vaccine doses, as recommended in modern vaccination schedules, drastically reduces the risk of vaccine failure. Outbreaks in highly vaccinated populations are rare and generally limited. The possibility of measles in vaccinated individuals should not discourage vaccination, which remains highly effective in preventing the disease and its serious complications.

What are the most serious complications of measles?

Complications of measles range from mild to potentially fatal. Pneumonia is the most common complication and leading cause of measles-related mortality, and can be primary viral or secondary bacterial. Acute encephalitis occurs in approximately 1 in every 1000 cases, manifesting with altered consciousness, seizures, and neurological deficits, with significant mortality rate and permanent sequelae in survivors. Otitis media is common, especially in children, and can lead to hearing loss. Diarrhea and dehydration are frequent, particularly in contexts of malnutrition. Subacute sclerosing panencephalitis (SSPE) is a rare but devastating complication that occurs years after acute infection, causing progressive neurological deterioration and invariably fatal. Pregnant women with measles have increased risk of premature delivery and fetal loss. Immunocompromised individuals may develop giant cell pneumonia and progressive encephalitis. Malnutrition, especially vitamin A deficiency, significantly increases the risk of serious complications.

How to prevent measles transmission in healthcare settings?

Prevention of nosocomial measles transmission requires rigorous measures due to the high contagiousness of the virus. Patients with suspected or confirmed measles should be placed on airborne isolation precautions immediately, preferably in a room with negative pressure. When negative pressure rooms are not available, use a private room with closed door. Healthcare workers should use N95 respirators or equivalent when entering the room, in addition to complete personal protective equipment. Only healthcare workers with evidence of immunity (documentation of two vaccine doses, positive serology, or documented history of measles) should care for these patients. Limit the number of exposed persons and perform rigorous contact tracing. Maintain precautions for 4 days after exanthem onset in immunocompetent individuals or throughout hospitalization in immunocompromised individuals. Institutions should maintain robust programs for verification of immunity and vaccination of healthcare workers.

Conclusion:

The ICD-11 code 1F03 for measles represents an essential tool for precise coding of this highly contagious viral disease. Proper understanding of when and how to apply this code, combined with knowledge of characteristic clinical manifestations, diagnostic methods, and differentiation of similar conditions, is fundamental for healthcare professionals. Correct coding not only facilitates appropriate clinical management and proper reimbursement, but plays a critical role in global epidemiological surveillance, essential for measles elimination efforts. With the transition from ICD-10 to ICD-11, familiarity with the new coding system and its expanded capabilities will allow more precise documentation and more sophisticated epidemiological analyses, contributing to better public health outcomes.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-03

Measles

Share